N-3 PUFA supplementation improves immune function and reduces the level of inflammation in gastrointestinal cancer patients postoperatively
Objectives:
Surgical resection remains the primary treatment for gastrointestinal (GI) malignancy including early-stage cancer. Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been reported to have beneficial clinical and immune-modulating effects in the prognosis of gastrointestinal cancer patients undergoing surgery. Therefore, this review article (meta-analysis) has been conducted.
What is the impact of n-3 PUFA supplementation on postoperative inflammation status and immune function of gastrointestinal cancer patients?